Cancer Policy FDA releases draft guidance on reducing testing on non-human primates for monoclonal antibodies December 05, 2025Vol.51 No.44By Jacquelyn Cobb
Cancer Policy Vaccine skeptic installed as CDC’s new second-in-command December 05, 2025Vol.51 No.44By Claire Marie Porter
Cancer Policy CMS cuts deal on four oncology drugs under Medicare December 05, 2025Vol.51 No.44By Sara Willa Ernst
Cancer Policy Medicare Part B premiums expected to rise almost 10% in 2026 December 05, 2025Vol.51 No.44By Sara Willa Ernst
Cancer Policy Hospitals sue to block CMS 340B drug rebate pilot December 05, 2025Vol.51 No.44By Sara Willa Ernst
Cancer Policy Trump administration puts new restrictions on federal student loan borrowing December 05, 2025Vol.51 No.44By Jacquelyn Cobb
Cancer Policy Trump cuts disrupted 383 clinical trials, affecting 74,000 trial participants November 21, 2025Vol.51 No.43By Jacquelyn Cobb
Cancer Policy NIH employee placed on leave after openly criticizing Trump November 21, 2025Vol.51 No.43By Claire Marie Porter
Cancer Policy Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer November 21, 2025Vol.51 No.43By Claire Marie Porter and Jacquelyn Cobb
Cancer Policy Makary, Prasad describe FDA’s new “plausible mechanism pathway” to get bespoke therapies to market sans RCT November 21, 2025Vol.51 No.43By Jacquelyn Cobb
